Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.47 |
| ▸ | TLR4 | O00206 | 5/20 | 0.39 |
| ▸ | SELP | P16109 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17091458 | 0.85 | MAPK1 (0.67) | MAPK1TLR4SELPCETP | |
| SCHEMBL17091464 | 0.85 | MAPK1 (0.67) | MAPK1TLR4SELPCETP | |
| SCHEMBL16694650 | 0.85 | MAPK1 (0.67) | MAPK1TLR4SELPCETP | |
| SCHEMBL12601163 | 0.82 | MAPK1 (0.52) | MAPK1SLC2A1TLR4GBA1 | |
| SCHEMBL12762999 | 0.81 | MAPK1 (0.53) | MAPK1SLC2A1TLR4GBA1 | |
| SCHEMBL12371581 | 0.81 | MAPK1 (0.53) | MAPK1SLC2A1TLR4GBA1 | |
| SCHEMBL14670337 | 0.77 | SLC2A1 (0.56) | MAPK1SLC2A1GBA1CETP | |
| SCHEMBL8630393 | 0.76 | SLC2A1 (0.54) | MAPK1SLC2A1GBA1CETP | |
| SCHEMBL21137947 | 0.74 | PYGB (0.50) | MAPK1SLC2A1TLR4GBA1 | |
| SCHEMBL13179119 | 0.74 | SLC2A1 (0.56) | SLC2A1CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2921179-A1 | Micellar nanoparticles containing antitumoral glycosides | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) | 2015-09-23 | — | — | EP | disclosed |